← FDA Drug Approvals (Drugs@FDA)

VOTRIENT

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2009-10-19

Drug application

FDA Application #
NDA022465
Application type
New Drug Application
Brand name
VOTRIENT
Generic name
PAZOPANIB HYDROCHLORIDE
Active ingredients
PAZOPANIB HYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
NOVARTIS
Manufacturer
Novartis Pharmaceuticals Corporation
First approval
2009-10-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown